ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "5: Getting Ready for the IVDR"
Episode Synopsis
IVDR Brings Huge Change to Manufacturers Distributing Products in Europe
The In Vitro Diagnostic Regulation (IVDR) means enormous upheaval for companies, as now up to 90% of products will need to be reviewed by a notified body before they are eligible for distribution in Europe under the IVDR. That’s a huge about-turn from the situation under the In Vitro Diagnostic Directive (IVDD), where approximately 80% of products were self-declared to the IVD Directive.
Listen to our expert, Terrance Thiel, in the latest PharmaLex podcast to learn more.
The In Vitro Diagnostic Regulation (IVDR) means enormous upheaval for companies, as now up to 90% of products will need to be reviewed by a notified body before they are eligible for distribution in Europe under the IVDR. That’s a huge about-turn from the situation under the In Vitro Diagnostic Directive (IVDD), where approximately 80% of products were self-declared to the IVD Directive.
Listen to our expert, Terrance Thiel, in the latest PharmaLex podcast to learn more.
More episodes of the podcast PharmaLex Talks
37: Optimizing revenue from mature products
18/07/2025
34: Environmental Risk Assessment and its growing importance in the German Pharma Strategy
14/04/2025
32: Commercialization Readiness
04/11/2024
31: Key Steps for Site Inspection Readiness
27/06/2024
30: CSS Overview
09/05/2024
In God we trust